CLINICAL TRIAL / NCT03615495

Flourish™ Pediatric Esophageal Atresia

  • Observational
  • Recruiting
  • NCT03615495
Eligibility Details Visit Clinicaltrials.gov

Contact Information

Flourish Pediatric Esophageal Atresia Device Post-Approval Study (Flourish)

This study is continued evaluation of the safety and probable benefit of the Flourish Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.

Gender
All

Age Group
12 Months and under

Accepting Healthy Volunteers?
No

Inclusion Criterion:

         - Patient treated for esophageal atresia with Flourish device starting May 12, 2017

At a Glance

National Government IDNCT03615495

IRB#IRB18-0966

Lead SponsorCook Research Incorporated

Lead PhysicianBethany Slater

Collaborator(s)N/A

EligibilityAll
12 Months and under
Recruiting